Global Outreach And Pipeline Programs Will Expand CNS Markets

Published
09 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$29.95
16.6% undervalued intrinsic discount
14 Aug
US$24.97
Loading
1Y
60.4%
7D
-1.9%

Author's Valuation

US$29.9

16.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on30 Apr 25
Fair value Increased 17%

Shared on23 Apr 25
Fair value Decreased 1.70%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 1.05%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 16%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 4.95%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 4.04%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.